Back to MW Marshall Wace, LLP

PBYIPBYI

Showing 6 of 19 quarters

Position history for MWMarshall Wace, LLP's holdings in Puma Biotechnology Inc

No. Marshall Wace exited its PBYI (Puma Biotechnology) position in Q4 2025. Its Q3 2025 13F listed 557,548 shares worth $3M. Marshall Wace already held PBYI in its Q4 2018 13F, the earliest on record, and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$5.95
0
2025-Q3
Increased
557,548
+659.5%
$3M0.0%$5.31
43
2025-Q2
Decreased
73,415
-66.1%
$251,8130.0%$3.43
0
2025-Q1
Increased
216,413
+152.9%
$640,5820.0%$2.96
39
2024-Q4
New
85,580
—
$261,0190.0%$3.05
32
2024-Q3
Exited
0
-100.0%
$00.0%$2.55
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used